Business Description
Endovia Health Sciences Inc
NAICS : 312130
SIC : 2084
ISIN : US84862C3025
Total Employee Number:
3Compare
Compare
Traded in other countries / regions
EDVA.USA IPO Date
2018-07-06Description
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | -14.64 | |||||
Debt-to-Equity | -0.41 | |||||
Debt-to-EBITDA | -0.47 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -303.28 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -88 | |||||
3-Year EBITDA Growth Rate | 25.2 | |||||
3-Year EPS without NRI Growth Rate | 27.6 | |||||
3-Year FCF Growth Rate | 47.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.33 | |||||
9-Day RSI | 35.95 | |||||
14-Day RSI | 39.01 | |||||
3-1 Month Momentum % | -49.57 | |||||
6-1 Month Momentum % | -83.04 | |||||
12-1 Month Momentum % | -95.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.05 | |||||
Quick Ratio | 0.05 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -42.9 | |||||
Shareholder Yield % | 32.63 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -13.57 | |||||
Operating Margin % | 3741.55 | |||||
Net Margin % | 4787.26 | |||||
EBITDA Margin % | 3778.95 | |||||
FCF Margin % | 1510.25 | |||||
OCF Margin % | 1510.25 | |||||
ROA % | -181.77 | |||||
ROIC % | -88.08 | |||||
3-Year ROIIC % | -1061.71 | |||||
ROC (Joel Greenblatt) % | -6233.45 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.59 | |||||
EV-to-EBITDA | -0.6 | |||||
EV-to-Revenue | -22.52 | |||||
EV-to-Forward-Revenue | 1.12 | |||||
EV-to-FCF | -1.49 | |||||
Earnings Yield (Greenblatt) % | -169.49 | |||||
FCF Yield % | -274.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:EDVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Endovia Health Sciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -0.361 | ||
| EPS (TTM) ($) | -23.95 | ||
| Beta | 0.6091 | ||
| 3-Year Sharpe Ratio | -0.18 | ||
| 3-Year Sortino Ratio | -0.49 | ||
| Volatility % | 83.88 | ||
| 14-Day RSI | 39.01 | ||
| 14-Day ATR ($) | 0.071937 | ||
| 20-Day SMA ($) | 0.39316 | ||
| 12-1 Month Momentum % | -95.08 | ||
| 52-Week Range ($) | 0.25 - 13.3996 | ||
| Shares Outstanding (Mil) | 6.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Endovia Health Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Endovia Health Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-19 | In 80 days | ||
| General meeting for 2026 | 2026-11-13 10:00 | In 75 days | ||
| Second quarter earnings results for 2026 | 2026-08-19 | 0.40 (+9.23%) | ||
| 0.25:1 Stock Split | 2026-07-27 | 0.37 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-20 | 0.78 (-0.15%) | ||
| Annual report for 2025 | 2026-04-15 | 1.48 (+0.27%) | ||
| Third quarter earnings results for 2025 | 2025-11-19 | 3.95 (-2.23%) | ||
| General meeting for 2025 | 2025-11-14 10:00 | 4.48 (-11.11%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 6.88 (-2.82%) | ||
| Annual report for 2024 | 2025-07-11 | 14.84 (+6.61%) |
Show
Entries
Endovia Health Sciences Inc Frequently Asked Questions
What is Endovia Health Sciences Inc(EDVA)'s stock price today?
The current price of EDVA is $0.31. The 52 week high of EDVA is $13.40 and 52 week low is $0.25.
When is next earnings date of Endovia Health Sciences Inc(EDVA)?
The next earnings date of Endovia Health Sciences Inc(EDVA) is 2026-11-19 Est..
Does Endovia Health Sciences Inc(EDVA) pay dividends? If so, how much?
Endovia Health Sciences Inc(EDVA) does not pay dividend.
Press Release
Articles on Endovia Health Sciences Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers